Skip to main content
S&P 5007,567.91-0.16%DOW52,114.08+0.66%NASDAQ25,296.29-0.55%BTC$76,826.00-1.20%ETH$2,248.53-0.35%GOLD$3,957.30+1.50%OIL$95.92-7.88%
Smart Investors Daily
SID Premium
ML

NASDAQ · MLAB

Mesa Laboratories, Inc.

Technology · Hardware, Equipment & Parts

$127.81

Down-$4.87 (-3.81%)

Updated Nov 2, 2026, 8:19 PM

SID Score

5.7/10

Composite research score

Smart Money

—

Institutional and insider signal

Market cap
431.9M
P/E ratio
-689.38
Dividend yield
0.50%
52-week range
$69.51 – $144.35
Volume
73.17K
Avg. volume
155.9K

Price performance · MLAB

MLAB price history

1M range · 20 trading sessions · Daily adjusted prices

Prices through Oct 30, 2026

MLAB closed at $127.81 after 20 trading sessions, down 10.14% for the selected period.

Last close
$127.81
Period change
-10.14%
Period low
$122.48
Period high
$142.23
Daily close
View OHLC price history
MLAB OHLC price history, latest 40 sessions
DateOpenHighLowCloseVolume
Oct 30, 2026$132.35$132.55$127.085$127.8173.17K
Oct 29, 2026$132.98$134.375$131.6501$133.0360.92K
Oct 28, 2026$128.35$133.78$128.35$131.32143.44K
Oct 27, 2026$130.86$133.41$128.66$129.2590.09K
Oct 26, 2026$128.87$131.19$128.87$129.8752.47K
Oct 23, 2026$127.90$129.625$124.95$128.6688.26K
Oct 22, 2026$129.27$131.01$127.59$129.1077.46K
Oct 21, 2026$124.21$129.78$123.76$129.2084.18K
Oct 20, 2026$123.25$128.27$122.52$125.1677.22K
Oct 19, 2026$123.79$125.4899$122.96$123.30575.32K
Oct 16, 2026$127.96$128.14$122.23$122.4874.35K
Oct 15, 2026$125.18$129.06$125.00$127.74100.25K
Oct 14, 2026$125.19$129.38$125.19$126.1679.58K
Oct 13, 2026$127.76$129.685$126.80$127.56108.69K
Oct 12, 2026$127.36$128.525$126.10$128.07105K
Oct 9, 2026$125.97$129.895$125.80$127.5193.37K
Oct 8, 2026$129.51$129.51$125.13$126.06153.68K
Oct 7, 2026$133.50$135.35$129.73$129.9670.38K
Oct 6, 2026$142.87$144.35$135.05$136.06103.26K
Oct 5, 2026$133.34$143.4312$133.34$142.23147.96K

Latest MLAB news

The latest Smart Investors Daily articles mentioning MLAB.

Stock researchCompany · Overview

MLAB research

Overview

Company profile and research snapshot.

Company profile

Mesa Laboratories Inc manufactures life sciences tools and critical quality control products. It operates in four divisions: Sterilization and Disinfection Control, which manufactures and sells biological, chemical, and cleaning indicators used to assess the effectiveness of sterilization, decontamination, disinfection, and cleaning processes. Clinical Genomics division develops, manufactures, and sells highly sensitive, low-cost, high-throughput genetic analysis tools and related consumables. The Biopharmaceutical Development division develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. The Calibration Solutions division develops, manufactures, sells, and services quality control products.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
—
Average target
$120.00
Implied upside
—
Analysts
—
MLAB recent ratings
DateFirmRatingTarget
Aug 14, 2026Wells FargoEqual-Weight—
Feb 4, 2026Wells FargoEqual-Weight—
Dec 15, 2025Wells FargoEqual-Weight—
Aug 8, 2025Wells FargoEqual-Weight—
May 30, 2025Wells FargoUnderweight—
Open full forecast

News briefing

No generated briefing is available yet.

Yahoo · Oct 28, 2026

Mesa Labs Announces Second Quarter Financial Results Release Date and Earnings Conference Call

Lakewood, Colo., Oct. 28, 2026 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa” or the “Company”), a global leader in the design and manufacture of critical quality control solutions and life sciences tools, today announced it will release financial results for its second fiscal quarter (“2Q27”) ended September 30, 2026 following market close on Monday, November 9, 2026. The Company will also hold its earnings conference call the same day at 4:30 p.m. Eastern Time t

Yahoo · Oct 13, 2026

Mesa Laboratories Announces Restructuring and Savings Plan to Reduce Annualized Costs by Approximately $9.3 Million and Reinvest Approximately $4.3 Million in Profitable Growth

The Restructuring Program focuses Clinical Genomics on profitability and adds resources in Sterilization and Disinfection Control, Calibration Solutions and AsiaLAKEWOOD, Colo., Oct. 13, 2026 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ: MLAB) (“Mesa,” “we,” “us” or “our”), a global leader in the design and manufacture of critical quality control solutions and life sciences tools, today announced a savings plan (the “Savings Plan”) expected to reduce annualized operating costs by approxim

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.

Featured By